This site is intended for healthcare professionals only
LoginRegister

Ophthalmology Dialogues

Roche Drops Muscle Disease Drug After Trial Failure

Roche Susvimo maintains vision over five years with two refills per year in people with nAMD

Basel: Roche has announced new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the...
View All

Latest News and Guidelines

What are Key Predictors and Management Factors for Orthokeratology Effectiveness in Myopic Children? Study Finds Out

What are Key Predictors and Management Factors for Orthokeratology Effectiveness in Myopic Children?...

Semaglutide and Liraglutide linked to Elevated Risk of Optic Nerve Damage in Seniors With Type 2 Diabetes: JAMA

Semaglutide and Liraglutide linked to Elevated Risk of Optic Nerve Damage in Seniors With Type 2...

Study Links High Stress Hyperglycemia Ratio to Diabetic Retinopathy Progression and Post-Surgery Complications

Study Links High Stress Hyperglycemia Ratio to Diabetic Retinopathy Progression and Post-Surgery...

Case Report Highlights Rare Endophthalmitis Following Botulinum Toxin Injection for Strabismus

Case Report Highlights Rare Endophthalmitis Following Botulinum Toxin Injection for Strabismus

Sports-Related Orbital Fractures Significant Contributor to Facial Trauma, Predominantly Affect Young Males: Study

Sports-Related Orbital Fractures Significant Contributor to Facial Trauma, Predominantly Affect...

Boehringer Ingelheims Vetmedin Becomes First USFDA-Approved Drug to Delay Heart Failure in Dogs

Boehringer Ingelheim, Re-Vana Therapeutics ink pact to develop extended release therapies for eye...

View All
X